Philips Clinical & Medical Affairs Global
Clinical trials sponsored by Philips Clinical & Medical Affairs Global, explained in plain language.
The clinical and medical affairs division of Philips, a global health technology company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New CT algorithm aims to clear up metal-related scan blur Results expected Sep 2026 (estimated)
- New CT tool aims to automate scan planning Results expected Sep 2026 (estimated)
- Laser zaps leg artery blockages in new trial Results expected Dec 2026 (estimated)
- AI-Powered heart scans could sharpen diagnosis Results expected Dec 2026 (estimated)
- AI clears up blurry CT scans for spine surgery patients Results expected Dec 2026 (estimated)
-
Could a Week-Long heart patch catch more dangerous rhythms than a One-Day test?
Diagnosis Stopped earlyThis study tested whether wearing a small, waterproof heart monitor (ePatch) for 7 days finds more treatable heart rhythm problems than the usual 24-hour Holter monitor in people who have fainted. About 55 adults with fainting symptoms were randomly assigned to either the 7-day e…
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Diagnosis
Last updated Jun 27, 2026 08:02 UTC
-
New blood flow test for leg artery disease shows promise in small study
Knowledge-focused Stopped earlyThis study tested a new, non-invasive way to measure blood flow in the legs of people with peripheral artery disease (PAD). Researchers compared the new method to standard ultrasound in 29 patients scheduled for a procedure to open blocked leg arteries. The goal was to see if the…
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Oxygen sensor study halted early – what it means for patient monitoring
Knowledge-focused Stopped earlyThis study tested how accurately Philips SpO2 sensors measure blood oxygen levels in 24 healthy adults aged 18-50. The sensors were compared to standard lab tests during rest. The study was terminated early, so the full results are not available.
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC